Harnessing the immune system
Immunotherapy — one of the most promising advances in modern medicine — uses a patient’s immune system to fight cancer cells. With your support, researchers at MSK are pioneering new immune-based therapies to prevent, treat, and cure cancer.
Together, we’ve made remarkable progress
Over the past two decades, MSK has consistently led the world in the study and development of cancer immunotherapies. Today, international headlines are regularly touting our newest accomplishments, including:
- A remarkable 100% remission rate in an MSK clinical trial of a new immunotherapy approach to treat a type of rectal cancer, which led to a Breakthrough Therapy Designation from the FDA — and a Time magazine cover story.
- The first-ever trial of experimental personalized messenger RNA-based therapeutic vaccines in pancreatic cancer.
And you’re advancing an even better tomorrow
Your donations will fund the next wave of discoveries and allow us to answer big questions, like what makes current immunotherapies work for some patients but not others, and how to make them work better for every person with cancer.
Kelly Spill's rectal cancer vanished in an MSK clinical trial using immunotherapy.
Immunotherapy in action
Your contributions propel revolutionary projects
Giving immune cells a power-up
With your support, MSK scientists are leading the way in CAR T cell therapy. In this approach, immune cells from a patient are removed from the body, armed with new proteins that recognize cancer, and given back to the patient.
Creating cancer vaccines
Targeted vaccines for cancer are one of today’s most exciting potential advances in treatment. The Olayan Center for Cancer Vaccines at MSK allows us to lead the field in researching and developing vaccines for a wide range of cancers.
Learn moreUniting the brightest minds
Your funds enable collaboration that gets new discoveries to patients as soon as possible. The Marie-Josée Kravis Center for Cancer Immunobiology brings our researchers together at a single hub to help innovations happen faster.
Read moreDeveloping new treatments
With CAR T cell therapy, a patient’s own immune cells are turned into a personalized treatment, which can take time. MSK researchers are making progress toward an off-the-shelf CAR T cell therapy that could help treat people faster.
Learn moreHelp us tackle the biggest questions in cancer
The MSK Campaign: Leading Science. Changing Lives.
The MSK community is raising $6 billion by 2030 to accelerate advances across six key strategic initiatives. Learn more and join us in our mission of ending cancer for life.
Learn more about The MSK Campaign